Company: HQL
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001104659-25-034659
Chunk: 7

Company: abrdn Life Sciences Investors
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 7
---
1-800-522-5465. You may also call for information on how to obtain directions to be able to register to attend a Meeting. The Election of Trustees Each Fund's Declaration of Trust, as amended to date (the "Declaration of Trust"), provides that its Board shall be divided into three classes with staggered terms. The term of office of each Class of Trustees for each Fund will expire in the year indicated in the following chart:

| Fund |     | Class A |      |     | Class B |      |     | Class C |      |
| HQH  |     |         | 2026 |     |         | 2027 |     |         | 2028 |
| HQL  |     |         | 2026 |     |         | 2027 |     |         | 2028 |
| THQ  |     |         | 2027 |     |         | 2028 |     |         | 2026 |
| THW  |     |         | 2028 |     |         | 2026 |     |         | 2027 |

Each Fund's Declaration of Trust provides that a majority of its Trustees shall fix the number of the entire Board of Trustees and that such number shall be at least three and no greater than fifteen. Each Fund's Board has fixed the number of Trustees at six. Proxies will be voted for the election of the following nominees for HQH, HQL, THQ and THW. In the event that a nominee is unable to serve for any reason when the election occurs, the accompanying Proxy will be voted for such other person or persons as the applicable Fund's Board may recommend. Each nominee is presently serving as a Trustee.

<div align='center'>5</div>

Each Board, including the Independent Trustees, upon the recommendation of such Board's Nominating and Corporate Governance Committee, which is composed entirely of Independent Trustees, has nominated the following nominees as Trustees to its Board:

| abrdn Healthcare Investors          |     | Kathleen Goetz (Class C Trustee, 3 year term ending 2028)    
 Todd Reit (Class C Trustee, 3 year term ending 2028)         |
| abrdn Life Sciences Investors       |     | Rose DiMartino (Class C Trustee, 3 year term ending 2028)    
 Todd Reit (Class C Trustee, 3 year term ending 2028)         |
| abrdn Healthcare Opportunities